The usefulness of patient treatment satisfaction questionnaire (PTSQ) in diabetes mellitus (DM) patients

Satisfaction with the latest-generation insulin pump (LGIP) was assessed in patients with diabetes mellitus enrolled in the Comparing Perception of Insulin Therapies for T1D Patients with the Aim to Improve Quality of Care (CHOICE) study. The Insulin Treatment Satisfaction Questionnaire (ITSQ), a measure of insulin treatment satisfaction, together with additional questions assessed respondents perceptions of glucose control, their satisfaction with major LGIP features and preference for the LGIP versus their previous treatment, was used. The LGIP (Animas® Vibe) was considered to be a better method for delivering insulin compared with their therapy before switching and was rated high for treatment satisfaction. These findings should be useful to clinicians when considering the possibility of transferring a patient from their existing treatment regimen to a LGIP.

Download Full-text

Clinical characteristics and patient treatment satisfaction with Humalog U-200 in patients with type 2 diabetes mellitus: an observational study

Journal of Drug Assessment ◽

10.1080/21556660.2019.1704415 ◽

2019 ◽

Vol 9 (1) ◽

pp. 8-12

Author(s):

Jil Mamza ◽

Uchena Anyanwagu ◽

Mohammed Alkharaiji ◽

Iskandar Idris

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Observational Study ◽

Treatment Satisfaction ◽

Clinical Characteristics ◽

Patient Treatment

Download Full-text

Osteoporosis Patient Treatment Satisfaction Questionnaire in postmenopausal women intermittently treated with oral bisphosphonates: the BRAVO study

Journal of Bone and Mineral Metabolism ◽

10.1007/s00774-011-0326-0 ◽

2011 ◽

Vol 30 (3) ◽

pp. 359-366 ◽

Cited By ~ 4

Author(s):

Ki Won Oh ◽

◽

Deog-Yoon Kim ◽

Yil-Seob Lee ◽

Moo Il Kang

Keyword(s):

Postmenopausal Women ◽

Treatment Satisfaction ◽

Patient Treatment ◽

Oral Bisphosphonates ◽

Satisfaction Questionnaire ◽

Osteoporosis Patient

Download Full-text

Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose?

Multiple Sclerosis Journal ◽

10.1177/1352458516657441 ◽

2016 ◽

Vol 23 (4) ◽

pp. 604-613 ◽

Cited By ~ 22

Author(s):

Patrick Vermersch ◽

Jeremy Hobart ◽

Catherine Dive-Pouletty ◽

Sylvie Bozzi ◽

Steven Hass ◽

...

Keyword(s):

Factor Analysis ◽

Construct Validity ◽

Treatment Satisfaction ◽

Internal Validity ◽

Internal Consistency Reliability ◽

Measurement Properties ◽

Patient Treatment ◽

Group Differences ◽

Satisfaction Questionnaire ◽

Global Satisfaction

Background: The Treatment Satisfaction Questionnaire for Medication (TSQM) was designed to assess patient treatment satisfaction in chronic diseases. Its performance has not been examined in multiple sclerosis (MS). The 14 items of the TSQM cover four domains: Effectiveness, Side Effects, Convenience, and Global Satisfaction. Objective: To evaluate performance of the TSQM in patients with relapsing MS, using data collected from the TENERE study (NCT00883337), in which 324 patients received oral teriflunomide or subcutaneous interferon beta-1a for ⩾48 weeks. Methods: Five measurement properties were examined using traditional psychometric methods: data completeness, scale-to-sample targeting, scaling assumptions, reliability (including test–retest), and construct validity (internal: item-level scaling success, confirmatory factor analysis, and exploratory factor analysis; external: convergence, discrimination, and group differences). Results: There were few (<2%) missing item data; domain scores could be computed for all patients. Score distributions were skewed toward higher satisfaction; two domains had marked ceiling effects. Scaling assumptions were supported. Internal consistency reliability was high (Cronbach’s α > 0.90). Internal validity tests supported item groupings. Correlations supported convergent and discriminant construct validity; hypothesis testing supported group differences validity. Conclusion: This investigation found the TSQM to be a useful tool, exhibiting good psychometric measurement properties in patients with relapsing MS in the TENERE study.

Download Full-text

Relación entre satisfacción con el tratamiento para diabetes y control glucémico en pacientes mayores de edad

Atención Familiar ◽

10.22201/fm.14058871p.2021.2.78797 ◽

2021 ◽

Vol 28 (2) ◽

pp. 95

Author(s):

Angélica Toledo Hernández ◽

Merily A. Liévanos Beltrán ◽

Alejandra Santillán Godínez

Keyword(s):

Diabetes Mellitus ◽

Treatment Satisfaction ◽

Diabetes Treatment ◽

Satisfaction Questionnaire ◽

Diabetes Treatment Satisfaction Questionnaire ◽

Para Determinar ◽

Hospital General ◽

Control Glucémico

Objetivo: evaluar la satisfacción del tratamiento para diabetes y su asociación con el control glucémico en pacientes que acuden a un módulo de control metabólico (Diabetimss). Métodos: estudio transversal analítico. Participaron pacientes con diabetes mellitus tipo 2 (dm2) mayores de dieciocho años inscritos en el programa Diabetimss del Hospital General Regional con Medicina Familiar (hgr/mf) No.1 del Instituto Mexicano del Seguro Social (imss); el muestreo fue no probabilístico por casos consecutivos. Se utilizó el cuestionario Diabetes Treatment Satisfaction Questionnaire (dtsq), se indagaron aspectos sociodemográficos, así como valores de hemoglobina glucosilada para determinar control glucémico. Resultados: se evaluaron 125 pacientes del módulo Diabetimss, 44.7% de los pacientes menores de 65 años presentó control glucémico y 95.8% señaló estar muy satisfecho con su tratamiento para diabetes. 68.9% de los pacientes mayores de 65 años tuvo un adecuado control glucémico y 93.1% refirió estar muy satisfecho con su tratamiento. Se realizó análisis bivariado mediante la prueba estadística exacta de Fisher para ambos grupos de edad no obteniéndose significancia estadística. Se obtuvo una or a nivel general de 0.04 (ic95% 0.16 - 5.76; p 0.96) entre control glucémico y satisfacción con el tratamiento. Conclusiones: no existió una asociación estadísticamente significativa entre control glucémico y satisfacción con el tratamiento para diabetes. Se deben de buscar estrategias alternas que fortalezcan el control metabólico en pacientes con dm2.

Download Full-text

Psychometric evaluation of the Osteoporosis Patient Treatment Satisfaction Questionnaire (OPSAT-Q™), a novel measure to assess satisfaction with bisphosphonate treatment in postmenopausal women

Health and Quality of Life Outcomes ◽

10.1186/1477-7525-4-42 ◽

2006 ◽

Vol 4 (1) ◽

Cited By ~ 24

Author(s):

Emuella M Flood ◽

Kathleen M Beusterien ◽

Hannah Green ◽

Richard Shikiar ◽

Robert W Baran ◽

...

Keyword(s):

Postmenopausal Women ◽

Treatment Satisfaction ◽

Psychometric Evaluation ◽

Patient Treatment ◽

Bisphosphonate Treatment ◽

Satisfaction Questionnaire ◽

Osteoporosis Patient

Download Full-text

DIABETES MELLITUS;

The Professional Medical Journal ◽

10.29309/tpmj/2017.24.11.649 ◽

2017 ◽

Vol 24 (11) ◽

pp. 1615-1620

Author(s):

Muhammad Aizaz Ashraf ◽

Talha Shamshad ◽

Muhammad Waseem Abbas ◽

Naveed Asghar ◽

Muhammad Umer Bin Arshad ◽

...

Keyword(s):

Diabetes Mellitus ◽

Side Effects ◽

Treatment Satisfaction ◽

Type I Diabetes ◽

Educational Status ◽

P Value ◽

Diabetic Patients ◽

Type I ◽

Type Ii ◽

Satisfaction Questionnaire

Objectives: Diabetes Mellitus being a major issue faced by developingcountries like Pakistan. Non-adherence is a major issue in achieving a desired therapeuticgoal. This study aims at determining relation with the drug non-adherence associated with thetreatment regime, treatment satisfaction and educational status of the person. Study Design:This was a cross sectional study. Place and Duration: This study was done at the Diabetesclinic, Nishtar hospital, Multan. Total 242 diabetic patients were studied over a period of 10months. Methodology: The inclusion criteria was set as patients who have been diagnosedwith Diabetes Type II and had been on oral hypoglycemic medications for about last 5 monthsor more. Those patients who were diagnosed with Type I diabetes and Type II diabetesless than 5 months were not included in the study. Also those patients who were on Insulintherapy were also excluded. Socio-demographic data was obtained along with therapy typeand educational status. Drug adherence level was studied with the 8-item Morisky (MMAS-8). Treatment satisfaction was studied with the help of treatment satisfaction questionnaire formedication. The data was analyzed on the SPSS version 23 with significant p-value <0.05.Results: Among 242 patients 152(62.81%) were females and 90(37.19%) were males. Meanage of the patients were 47.68±15.13 years. Patients on combination therapy were (n=134,55.3%) and on monotherapy were (n=108, 44.6%). Mean adherence score was 5.4±1.1.Themean for four domains of Treatment Satisfaction Questionnaire for Medication(TSQM) were:effectiveness= 66.93±15.27, side effects=32.09±26.91, convenience =62.59±14.49 andsatisfaction= 65.49±16.13.Non-adherence was found to be associated with age, illiteracy,side-effects, satisfaction and convenience (p<0.05). Conclusion: Non-adherence must beovercome in patients to achieve appropriate glucose levels. Significant factors affecting theadherence levels were Illiteracy, Side effects, convenience and satisfaction of the patient. Publicawareness campaigns and regular clinic visits should be encouraged. Drugs having lower sideeffects,higher satisfaction levels and combined generics for once daily dosing having greaterconvenience should be used.

Download Full-text